Dr. Weifeng Mao is the Director of Biology at Apeiron Therapeutics. He has more than 18 years experience in the pharmaceutical industry. He has deep expertise in building and optimizing in vitro screening and characterization platforms to discover novel drugs. Prior to joining Apeiron, Dr. Mao worked at WuXi AppTec where he established several in vitro screening platforms. Dr. Mao has also held several project leader responsibilities at international companies, including HutchMed and Everest, leading efforts across a range of functions within drug discovery and non-clinical development. Dr. Mao received his Ph.D.in physiology at the East China National University.